BML-277 T2033
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BML-277 is a selective checkpoint kinase 2 (Chk2) inhibitor.
CAS nr:
516480-79-8
Purity:
98%
Molecular Weight:
363,8
SMILES:
NC(=O)c1ccc2nc([nH]c2c1)-c1ccc(Oc2ccc(Cl)cc2)cc1
Formula:
C20H14ClN3O2
Pathway:
Cell Cycle/Checkpoint,Apoptosis
Target:
Chk,Apoptosis
